02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

HEPATOLOGY, VOLUME 62, NUMBER 1 (SUPPL) AASLD ABSTRACTS 1097A<br />

1821<br />

Mathematical model for early detection of hepatocellular<br />

carcinoma on top of HCV infection<br />

Abdelrahman Zekri, Amira S. Youssef, Yasser M. Bakr, Reham<br />

Mohamed Gabr, Ola Ahmed, Mohamed Abouelhoda; Virology<br />

and immunology Unit, Cancer Biology, National Cancer Institute,<br />

Cairo, Egypt<br />

Background: We investigated whether combinations of serum<br />

Intercellular Adhesion Molecules (sICAM-1), Beta catenin<br />

(β-catenin), Interleukin 8 (IL-8), Proteasome and soluble Tumor<br />

Necrosis Factor Receptor II (sTNF-RII) or subsets of them with<br />

AFP, used with logistic disease predictor models, could facilitate<br />

the early detection of hepatocellular carcinoma (HCC).<br />

Methods: Serum levels of IL-8, sICAM-1, sTNF-RII, Proteasome<br />

and β-catenin were measured in 479 subjects (192<br />

HCC associated with HCV infection; 96 HCV related liver<br />

cirrhosis (LC); 96 chronic hepatitis C (CHC) and 95 healthy<br />

controls). The R package and different modules for binary<br />

and multi-class classifiers based on generalized linear models<br />

were used to model the data. ROC curve analysis was<br />

used to find the best cutoffs differentiating among different<br />

groups. Results: We revealed mathematical models, based on<br />

binary classifier, made up of unique panel of biomarkers that<br />

improved the individual performance of AFP for the discrimination<br />

of HCC from benign liver disease. For the discrimination<br />

of HCC group from LC group, using a mathematical model<br />

[-1.133(E+01) +7.380* Proteasome + (1.081E-03)*sICAM-1+<br />

(2.574E-01)*β-catenin + (1.597E-02)*AFP] with cutoff 0.6552<br />

has achieved 98.8% specificity and 89.1% sensitivity. For the<br />

discrimination of HCC group from CHC group, a mathematical<br />

model [-1.040*(e+01) + (1.416e+00)*Proteasome +<br />

(2.024e-03)*IL-8+ (4.096e-03)*sICAM-1+ (4.251e-04)*sT-<br />

NF-RII+ (2.567e-01)*β-catenin + (2.442e-02)*AFP] with cutoff<br />

0.744 has achieved 96.8% specificity and 89.7% sensitivity.<br />

Also, we have derived an algorithm for resolving the multi-class<br />

classification problem by using three successive mathematical<br />

models. First, use the mathematical model [-1.10E+01+6.83*<br />

Proteasome + (1.29E-03)*sTNF—RII + (2.83E-01)*AFP]<br />

with cutoff 0.764 to discriminate healthy controls from disease<br />

cases. For disease cases, discriminate HCC cases from<br />

HCV cases (cases with LC and CHC) using the mathematical<br />

model [-1.191(E+01) + (3.222E+00)* Proteasome +<br />

(3.813E-04)*IL-8 + (1.518E-03)*sICAM-1 + (6.481E-04)*sT-<br />

NF-RII + (2.906E-01)* β-Catenin + (1.931e-02)*AFP] with<br />

cutoff 0.712. If the cases were HCV, proceed to discriminate<br />

LC cases from CHC cases using the mathematical model<br />

[-1.016e+01 + (-4.487e+00)*Proteasome + (2.086e-03)*sI-<br />

CAM-1 + (1.858e-03)*sTNF-RII+ (-2.984e-01)* β-Catenin +<br />

(2.169e-02)*AFP] with cutoff 0.582. Conclusion: Our proposed<br />

mathematical models can differentiate not only between<br />

HCC and other studied groups but also between all studied<br />

groups in non-invasive, inexpensive and rapid manner. Key<br />

words: Hepatocellular carcinoma, AFP, sICAM-1, β-catenin,<br />

IL-8, sTNF-RII, Proteasome.<br />

Disclosures:<br />

The following authors have nothing to disclose: Abdelrahman Zekri, Amira<br />

S. Youssef, Yasser M. Bakr, Reham Mohamed Gabr, Ola Ahmed, Mohamed<br />

Abouelhoda<br />

1822<br />

Hepatitis C Seropositivity is not as high as Western<br />

Countries in the Population Born Between 1945-1965<br />

According to Turkey Nationwide Hepatitis Prevalence<br />

Study (TURKHEP 2010)<br />

Osman C. Ozdogan 1 , Nurdan Tozun 2 , Sabahattin Kaymakoglu 3 ,<br />

Ramazan Idilman 4 , Zeki Karasu 5 , Ulus S. Akarca 5 ; 1 Gastroenterology,<br />

Marmara University Medical School, Istanbul, Turkey;<br />

2 Gastroenterology, Acibadem University Medical School, Istanbul,<br />

Turkey; 3 Gastroenterology, Istanbul University Medical Faculty,<br />

Istanbul, Turkey; 4 Gastroenterology, Ankara Universit Faculty of<br />

Medicine, Istanbul, Turkey; 5 Gastroenterology, Ege University<br />

Medical Faculty, Istanbul, Turkey<br />

Aim&Methods: Hepatitis C infection is more prevalent in the<br />

“Baby Boomer Population” those born between 1945 and<br />

1965 in USA and Western Countries. Although Turkey was<br />

not involved in World War II, birth rates were increased after<br />

1945 in Turkey. However, this population can not be defined<br />

as “Baby Boomers” since they have different properties. We<br />

aimed to determine the anti-HCV seropositivity in the population<br />

born between the years of 1945-1965 from the data<br />

of Turkey Nationwide Hepatitis Prevalence Study (TURKHEP)<br />

which was presented in AASLD in 2010 by Turkish Association<br />

for the Study of Liver Disease (TASL). A total of 5533 volunteers<br />

were screened in TURHEP Study, performed via home<br />

visits in 2009-2010 with volunteers living in urban and rural<br />

areas of 23 cities located in EUROSTAT NUTS 2 regions of<br />

Turkey which were determined based on two stage stratified<br />

sampling method. The participants were selected according<br />

to randomized sampling method of Statistics Institute of Turkey<br />

(TUIK). Participants’ socio-demographic features, anthropometrics,<br />

medical history, concomitant medications and presence<br />

of risk factors were recorded and blood samples were<br />

collected for the analysis of serum HBV, HDV, HCV markers,<br />

ALT and AST levels. Anti-HCV seropositivity and HCV RNA<br />

status was recruited from the TURKHEP data and compared<br />

with the population born after 1965. Results: TURKHEP data<br />

analysis included 5460 participants with data available on<br />

seroprevalence and risk factors for hepatitis C infection inwhich<br />

1980 participants (1037 female/943 male) borned between<br />

the years of 1945-1965 were recruited. Overall, 0.95% of the<br />

subjects were reactive for anti-HCV antibodies in whole population<br />

whereas Anti-HCV seropositive subjects were 28 out of<br />

1980 subjects in the population born between 1945-1965 at<br />

a rate of 1.4 % which is 1.5 times higher than the whole population.<br />

Half of these subjects were HCV RNA positive by the<br />

Real time PCR instrument, Rotor-Gene Q (QIAGEN, Germany).<br />

However among the subjects borned after 1965, Anti-HCV<br />

seropositive subjects were 23 out of 3460 subjects at a rate of<br />

0.7%. Conclusion: Eventhough the HCV seropositivity rate was<br />

higher than the whole Turkish population in Turkish population<br />

born between the years of 1945-1965, this rate of increase did<br />

not reach the higher rates of Western Baby Boomer Population<br />

showing the different transmission routes of HCV infection in<br />

Turkey.<br />

Disclosures:<br />

Ulus S. Akarca - Advisory Committees or Review Panels: GILEAD, BMS, MSD,<br />

AbbVie<br />

The following authors have nothing to disclose: Osman C. Ozdogan, Nurdan<br />

Tozun, Sabahattin Kaymakoglu, Ramazan Idilman, Zeki Karasu

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!